Evidence map›Paper›PMID 25973312›Full record

ArticleAmerican journal of cancer research2015

Wnt signaling through Snail1 and Zeb1 regulates bone metastasis in lung cancer.

Xinghai Yang, Lei Li, Quan Huang, Wei Xu, Xiaopan Cai, Jishen Zhang, Wangjun Yan, Dianwen Song, Tielong Liu, Wang Zhou and 4 more

Abstract read
In one paragraph

Article in American journal of cancer research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Xinghai YangDepartment of Orthopedic Oncology, Changzheng Hospital, The Second Military Medical University 415 Fengyang Road, Shanghai 200003, China.
Lei LiDepartment of Orthopedic Oncology, Changzheng Hospital, The Second Military Medical University 415 Fengyang Road, Shanghai 200003, China.
Quan HuangDepartment of Orthopedic Oncology, Changzheng Hospital, The Second Military Medical University 415 Fengyang Road, Shanghai 200003, China.
Wei XuDepartment of Orthopedic Oncology, Changzheng Hospital, The Second Military Medical University 415 Fengyang Road, Shanghai 200003, China.
Xiaopan CaiDepartment of Orthopedic Oncology, Changzheng Hospital, The Second Military Medical University 415 Fengyang Road, Shanghai 200003, China.
Jishen ZhangDepartment of Orthopedic Oncology, Changzheng Hospital, The Second Military Medical University 415 Fengyang Road, Shanghai 200003, China.
Wangjun YanDepartment of Orthopedic Oncology, Changzheng Hospital, The Second Military Medical University 415 Fengyang Road, Shanghai 200003, China.
Dianwen SongDepartment of Orthopedic Oncology, Changzheng Hospital, The Second Military Medical University 415 Fengyang Road, Shanghai 200003, China.
Tielong LiuDepartment of Orthopedic Oncology, Changzheng Hospital, The Second Military Medical University 415 Fengyang Road, Shanghai 200003, China.
Wang ZhouDepartment of Orthopedic Oncology, Changzheng Hospital, The Second Military Medical University 415 Fengyang Road, Shanghai 200003, China.
Zhenxi LiDepartment of Orthopedic Oncology, Changzheng Hospital, The Second Military Medical University 415 Fengyang Road, Shanghai 200003, China.
Cheng YangDepartment of Orthopedic Oncology, Changzheng Hospital, The Second Military Medical University 415 Fengyang Road, Shanghai 200003, China.
Yongyan DangShanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, School of Life Sciences, East China Normal University 500 Dongchuan Road, Shanghai 200241, China.
Jianru XiaoDepartment of Orthopedic Oncology, Changzheng Hospital, The Second Military Medical University 415 Fengyang Road, Shanghai 200003, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wnt-β-catenin signaling participates in the epithelial-mesenchymal transition (EMT) in a variety of cancers; however, its role in lung cancer induced bone metastasis and the underlying mechanisms remain unclear. Here, we demonstrate that β-catenin, Snail1 and Zeb1 were significantly upregulated in bone metastasis tissues from human and mouse compared with the normal controls. E-cadherin expression is negatively regulated by Zeb1, Snail1 and β-catenin during bone metastasis tissues induced by lung cancer. Knocking down Zeb1 and Snail1 in lung cancer cell lines showed increased E-cadherin mRNA expression and less invasion compared with the original cell lines. In addition, β-catenin knockdown led to the increase of E-cadherin and the decrease of Zeb1 and Snail1, which in turn inhibited the invasive properties of lung cancer. Our results demonstrated that Wnt signaling through Snail1 and Zeb1 regulates bone metastasis in lung cancer.

Indexed as

Bone metastasisE-cadherinSnail1Zeb1β-catenin

Identifiers

PMID25973312
PMCPMC4396030

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.